Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes

Abstract

Therapeutic options for thymoma-associated myasthenia gravis (MG) patients complicated with hypertension and/or diabetes post thymectomy are often conventional steroids. As the prevalence of diabetes and hypertension globally increases, other therapeutic options for these patients are of great importance.

Keywords

• myasthenia gravis
• treatment
• thymectomy
• hypertension
• diabetes